Emil Kakkis | Chief Executive Officer
Ultragenyx Pharmaceutical

Emil Kakkis, Chief Executive Officer, Ultragenyx Pharmaceutical

Appearances:



World Orphan Drug Congress USA 2022 - Day 1 @ 08:40

Keynote Address: Drug Development in the 21st Century - The use of primary disease activity biomarkers to establish efficacy

last published: 29/Jun/22 01:45 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Claire Murphy
claire.murphy@terrapinn.com
t/ +1 646 619 1784

 

 

 

Marketing & Press Opportunities

 
 

Taylor Post 
taylor.post@terrapinn.com
t/ +1 646 619 1785